Please try another search
Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal health, biotech, crop protection, and specialty chemicals companies in India. The company operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment manufactures pesticides and herbicides, which include diuron tech, temephos tech, thiacloprid tech, clothianidin tech, dichloroaniline, N-bromosuccinimide, prothioconazole technical, trifloxystrobin technical, and BIT. It also collaborates with other companies and offer solutions in contract research, custom synthesis, and custom manufacturing of intermediates and active ingredients. In addition, the company offers human health products, such as anti-convulsant, anti-emetic, anti-histaminic, anti-depressant, anti-psychotic, anti-lipemic, hemorheologic, anti-diabetic, anti-thrombotic, anti-hypertensive, anti-inflammation, and analgesic; animal health products, such as anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, and NSAID; and specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. It also exports its products. The company operates in the United States, Canada, Europe Union, Japan, Latin America, and internationally. Hikal Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.
Name | Age | Since | Title |
---|---|---|---|
Shivani Bhasin Sachdeva | 47 | 2019 | Independent Director |
Prakash Vasantlal Mehta | 81 | 1994 | Independent Non-Executive Director |
Goverdhan Mehta | 80 | - | Member of Scientific Advisory Board |
Jai Vishwanath Hiremath | 75 | 2018 | Founder & Executive Chairman |
Sameer Jai Hiremath | 49 | 2008 | MD & Executive Director |
Shrikrishna Kiran Adivarekar | 42 | 2021 | Additional Independent Non-Executive Director |
Vinnakota Ramachandra Kaundinya | 68 | 2023 | Independent Director |
Sugandha Jaidev Hiremath | 72 | 1992 | Non-Executive Director |
Axel Kleemann | 84 | 2014 | Member of Scientific Advisory Board |
K. Nagarajan | 94 | - | Member of Scientific Advisory Board |
Shivani Bhasin Sachdeva | 51 | 2019 | Independent Non-Executive Director |
Amit Babasaheb Kalyani | 49 | 2010 | Non-Executive Director |
Ravi Brijmohan Kapoor | 63 | 2024 | Director |
Berjis Minoo Desai | 68 | 2023 | Independent Director |
Sarangan Suresh | 61 | 2024 | Director |
Ranjana S. Salgaocar | 70 | 2024 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review